Shashikant Ray

808 total citations
21 papers, 540 citations indexed

About

Shashikant Ray is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Shashikant Ray has authored 21 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Genetics. Recurrent topics in Shashikant Ray's work include SARS-CoV-2 and COVID-19 Research (6 papers), Bacterial Genetics and Biotechnology (5 papers) and Bacteriophages and microbial interactions (4 papers). Shashikant Ray is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Bacterial Genetics and Biotechnology (5 papers) and Bacteriophages and microbial interactions (4 papers). Shashikant Ray collaborates with scholars based in India, United States and Rwanda. Shashikant Ray's co-authors include Aroni Chatterjee, Rajni Khan, Amresh Prakash, Abhijeet Kumar, Jitendra Subhash Rane, Preeti Pandey, Dulal Panda, Pawan Kumar, Gautam Das and Shradha Khater and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemistry.

In The Last Decade

Shashikant Ray

18 papers receiving 534 citations

Peers

Shashikant Ray
Joseph T. Ortega United States
Nishant Shekhar India
Vimal K. Maurya India
Mohammed Al‐Nazawi Saudi Arabia
Carina Stiller Germany
Naveen Vankadari Australia
N. Maltseva United States
Clara Rolland France
Dana Stein Israel
Sarah E. St. John United States
Joseph T. Ortega United States
Shashikant Ray
Citations per year, relative to Shashikant Ray Shashikant Ray (= 1×) peers Joseph T. Ortega

Countries citing papers authored by Shashikant Ray

Since Specialization
Citations

This map shows the geographic impact of Shashikant Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashikant Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashikant Ray more than expected).

Fields of papers citing papers by Shashikant Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashikant Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashikant Ray. The network helps show where Shashikant Ray may publish in the future.

Co-authorship network of co-authors of Shashikant Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Shashikant Ray. A scholar is included among the top collaborators of Shashikant Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shashikant Ray. Shashikant Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Peter S., Cole R. Michel, Shashikant Ray, et al.. (2025). Deacetylation of SOD3 by sirtuins restores furin cleavage. PubMed. 14. 100062–100062.
2.
Kumar, Pawan, Indu Kumari, Rajendra Prasad, et al.. (2025). Elucidating the binding specificity of interactive compounds targeting ATP-binding cassette subfamily G member 2 (ABCG2). Molecular Diversity. 29(6). 5635–5648. 1 indexed citations
3.
Upadhyay, Vaibhav, Shashikant Ray, Sudipta Panja, et al.. (2024). Biophysical characterization of the dystrophin C-terminal domain: Dystrophin interacts differentially with dystrobrevin isoforms. Journal of Biological Chemistry. 300(12). 108002–108002.
4.
Kumar, Pawan, Rajni Khan, Anisha Kumari, et al.. (2024). Hydroxyethylamine based analog targets microtubule assembly: an in silico study for anti-cancerous drug development. Scientific Reports. 14(1). 31381–31381. 1 indexed citations
5.
Chatterjee, Aroni, Rajni Khan, Prasanta K. Sahoo, et al.. (2024). Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials. Archives of Microbiology. 206(11). 449–449.
6.
Khan, Rajni, et al.. (2024). Alterations in Circadian Rhythms, Sleep, and Physical Activity in COVID-19: Mechanisms, Interventions, and Lessons for the Future. Molecular Neurobiology. 61(12). 10115–10137. 3 indexed citations
7.
Kumar, Abhijeet, Jitendra Subhash Rane, Rajni Khan, et al.. (2022). Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction. Scientific Reports. 12(1). 17038–17038. 6 indexed citations
8.
Khater, Shradha, Pawan Kumar, Nandini Dasgupta, et al.. (2021). Combining SARS-CoV-2 Proofreading Exonuclease and RNA-Dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput in silico Screening. Frontiers in Microbiology. 12. 647693–647693. 48 indexed citations
9.
Khan, Rajni, et al.. (2020). Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy. Open Biology. 10(9). 200174–200174. 15 indexed citations
10.
Pandey, Preeti, Jitendra Subhash Rane, Aroni Chatterjee, et al.. (2020). Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. Journal of Biomolecular Structure and Dynamics. 39(16). 6306–6316. 195 indexed citations
11.
Rane, Jitendra Subhash, Preeti Pandey, Aroni Chatterjee, et al.. (2020). Targeting virus–host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19. Journal of Biomolecular Structure and Dynamics. 39(15). 5768–5778. 35 indexed citations
12.
Chatterjee, Aroni, et al.. (2020). Nucleic acid-based therapy for coronavirus disease 2019. Heliyon. 6(9). e05007–e05007. 35 indexed citations
13.
Khan, Rajni, et al.. (2020). Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19. Gene. 768. 145313–145313. 28 indexed citations
14.
Chatterjee, Aroni, et al.. (2020). Combating COVID-19 with mesenchymal stem cell therapy. Biotechnology Reports. 26. e00467–e00467. 69 indexed citations
15.
Chatterjee, Aroni, et al.. (2020). BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope?. SHILAP Revista de lepidopterología. 7. 100049–100049. 16 indexed citations
16.
17.
Ray, Shashikant, et al.. (2015). ZapC promotes assembly and stability of FtsZ filaments by binding at a different site on FtsZ than ZipA. International Journal of Biological Macromolecules. 81. 435–442. 12 indexed citations
18.
Ray, Shashikant, et al.. (2015). BT‐benzo‐29 inhibits bacterial cell proliferation by perturbing FtsZ assembly. FEBS Journal. 282(20). 4015–4033. 21 indexed citations
19.
Ray, Shashikant, et al.. (2014). Antimicrobial Peptide CRAMP (16–33) Stalls Bacterial Cytokinesis by Inhibiting FtsZ Assembly. Biochemistry. 53(41). 6426–6429. 24 indexed citations
20.
Ray, Shashikant, Ashutosh Kumar, & Dulal Panda. (2012). GTP Regulates the Interaction between MciZ and FtsZ: A Possible Role of MciZ in Bacterial Cell Division. Biochemistry. 52(2). 392–401. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph T. Ortega Breakdown of academic impact, for papers by Nishant Shekhar Breakdown of academic impact, for papers by Vimal K. Maurya Breakdown of academic impact, for papers by Mohammed Al‐Nazawi Breakdown of academic impact, for papers by Carina Stiller Breakdown of academic impact, for papers by Naveen Vankadari Breakdown of academic impact, for papers by N. Maltseva Breakdown of academic impact, for papers by Clara Rolland Breakdown of academic impact, for papers by Dana Stein Breakdown of academic impact, for papers by Sarah E. St. John
Rankless by CCL
2026